AI IntelligenceJun 18, 2026Primary Market
Article
Faeth Therapeutics, Inc. · Not disclosed · Unbekannt
Faeth Therapeutics has entered into a material definitive agreement, suggesting a funding round. The company focuses on therapeutic nutrition for cancer treatment.
Data Cube AI EditorialSource: SEC EDGAR
01
Source Brief
Faeth Therapeutics has entered into a material definitive agreement, suggesting a funding round. The company focuses on therapeutic nutrition for cancer treatment.
02